FB2026_03 , released September 17, 2026
Chemical: gaboxadol
Open Close
General Information
Name
gaboxadol
FlyBase ID
FBch0000558
ChEBI Name
gaboxadol
ChEBI ID
CHEBI:34373
PubChem Name
Gaboxadol
PubChem ID
CID:3448
Chemical Structure
Chemical structure of gaboxadol
gaboxadol
InChIKey

ZXRVKCBLGJOCEE-UHFFFAOYSA-N

Definition (ChEBI)

ChEBI: 4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol is an oxazole. A member of the class of oxazolopyridines that is 2,3,4,5,6,7-hexahydro[1,2]oxazolo[5,4-c]pyridine substituted by an oxo group at position 3. ChEBI: Gaboxadol is an oxazolopyridine. It has a role as a sedative and a GABAA receptor agonist.

Roles Classification (ChEBI)
Comment
Synonyms and Secondary IDs (22)
Synonyms
4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol
(ChEBI, 2019-, PubChem, 2019-, Dissel et al., 2017, Kim et al., 2017, Yap et al., 2017, Berry et al., 2015)
4,5,6,7-tetrahydro[1,2]oxazolo[5,4-c]pyridin-3(2H)-one
(ChEBI, 2019-)
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol
(De Nobrega et al., 2022)
4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one
(ChEBI, 2019-)
4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
(PubChem, 2019-, Kim et al., 2017)
4,5,6,7-tetrahyrdoisoxazolopyridin-3-ol
(Anthoney et al., 2023)
64603-91-4
(PubChem, 2019-)
DTXSID0045206
(PubChem, 2019-)
Gaboxadol
(De Nobrega et al., 2022, Huang et al., 2022, van Alphen et al., 2021, Yap et al., 2017, Berry et al., 2015)
Gaboxadolum
(PubChem, 2019-)
LU 2030
(ChEBI, 2019-)
LU-02030
(ChEBI, 2019-)
LU-2-030
(ChEBI, 2019-)
Lu 02-030
(ChEBI, 2019-, PubChem, 2019-)
Lu-02-030
(PubChem, 2019-)
MK-0928
(ChEBI, 2019-, PubChem, 2019-)
OV-101
(ChEBI, 2019-)
OV101
(ChEBI, 2019-)
PubChem:3448
(PubChem, 2019-)
THIP
(Peng et al., 2024, De Nobrega et al., 2022, Huang et al., 2022, ChEBI, 2019-, PubChem, 2019-, Dissel et al., 2017)
gaboxadol
(Ji et al., 2026, Cuddapah et al., 2025, Ortiz-Vega et al., 2024, Anthoney et al., 2023, Dissel et al., 2020, PubChem, 2019-)
gaboxadolum
(ChEBI, 2019-)
Secondary FlyBase IDs
    References (18)